Table 4.
No. | MPS type | Gender | Age (years) | Right eye or left eye | Visual acuity | Sphere | Cylinder | Axis of cylinder | Refraction (spherical equivalent) | Amblyopia | Corneal opacity | Lens opacity | Optic disc | IOP (mmHg) | Retinal appearance | VEP |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IV‐1 | IVA | M | 1.1 | R | Follow light | +0.5 | −1.5 | 180 | −0.25 | N | + | Normal | Normal | ‐ | Normal | ‐ |
L | Follow light | +0.5 | −1.5 | 180 | −0.25 | |||||||||||
IV‐2 | IVA | M | 5.6 | R | 0.2 (6/30) | +3.0 | −3.0 | 13 | +1.50 | N | + | Normal | Normal | 20.1 | Normal | ‐ |
L | 0.1 (6/60) | 0 | +3.0 | 80 | +1.50 | Y | 17.5 | |||||||||
IV‐3 | IVA | M | 5.8 | R | 0.6 (6/10) | 0 | +3.0 | 89 | +1.50 | N | + | Normal | Normal | ‐ | Normal | ‐ |
L | 0.6 (6/10) | +0.5 | +2.25 | 91 | +1.63 | |||||||||||
IV‐4 | IVA | F | 6.4 | R | 0.2 (6/30) | +2.5 | +2.5 | 85 | +3.75 | N | + | Nuclear sclerosis | Normal | 21 | Normal | ‐ |
L | 0.3 (6/20) | +2.5 | +2.5 | 90 | +3.75 | 18 | ||||||||||
IV‐5 | IVA | F | 6.5 | R | 0.4 (6/15) | −0.75 | −1.5 | 1 | −1.50 | N | + | Normal | Normal | ‐ | Normal | ‐ |
L | 0.4 (6/15) | 0 | −0.75 | 25 | −0.38 | |||||||||||
IV‐6 | IVA | M | 7.2 | R | 0.4 (6/15) | +0.75 | +2.5 | 90 | +2.00 | Y | + | Normal | Normal | 17 | Normal | ‐ |
L | 0.4 (6/15) | +0.75 | +2.5 | 84 | +2.00 | 15 | ||||||||||
IV‐7 | IVA | M | 9.0 | R | 0.5 (6/12) | +0.25 | +0.25 | 52 | +0.38 | N | + | Normal | Normal | ‐ | Normal | ‐ |
L | 0.7 (6/8.6) | +0.25 | +1.75 | 37 | +1.13 | |||||||||||
IV‐8 | IVA | F | 10.9 | R | 1.0 (6/6) | +0.25 | −0.75 | 162 | −0.13 | N | + | Normal | Normal | ‐ | Normal | ‐ |
L | 1.0 (6/6) | +0.5 | −1.25 | 180 | −0.13 | |||||||||||
IV‐9 | IVA | M | 11.6 | R | 0.6 (6/10) | −1.0 | −0.5 | 110 | −1.25 | N | Clear | Normal | Normal | ‐ | Normal | ‐ |
L | 0.6 (6/10) | −1.0 | −0.25 | 73 | −1.13 | |||||||||||
IV‐10 | IVA | F | 13.6 | R | 0.3 (6/20) | +3.5 | −5.0 | 170 | +1.00 | N | + | Normal | Normal | ‐ | Normal | ‐ |
L | 0.4 (6/15) | +4.5 | −5.0 | 5 | +2.00 | |||||||||||
IV‐11 | IVA | F | 14.2 | R | 0.3 (6/20) | +2.5 | −3.5 | 169 | +0.75 | Y | + | Normal | Normal | ‐ | Normal | ‐ |
L | 0.4 (6/15) | +3.0 | −4.5 | 177 | +0.75 | |||||||||||
IV‐12 | IVA | F | 15.7 | R | 0.3 (6/20) | +1.0 | −1.75 | 140 | +0.13 | N | + | Normal | Normal | 26.9 | Normal | ‐ |
L | 0.9 (6/6.7) | −0.25 | −0.75 | 26 | −0.63 | 27 | ||||||||||
IV‐13 | IVA | F | 15.8 | R | 0.5 (6/12) | +3.0 | −3.0 | 180 | +1.50 | N | ++ | Normal | Normal | ‐ | Vitreous opacities | ‐ |
L | 0.4 (6/15) | +6.0 | −5.0 | 175 | +3.50 | |||||||||||
IV‐14 | IVA | M | 15.9 | R | 1.0 (6/6) | +2.25 | +1.00 | 65 | +2.75 | N | + | Normal | Normal | 15.2 | Normal | Normal |
L | 0.9 (6/6.7) | +2.25 | +1.5 | 98 | +3.00 | 14.3 | ||||||||||
IV‐15 | IVA | F | 19.2 | R | 0.8 (6/7.5) | −2.25 | −2.25 | 150 | −3.38 | N | + | Normal | Cupped 0.5 cup:disc | 25.1 | Normal | ‐ |
L | 0.4 (6/15) | −1.75 | −1.75 | 55 | −2.63 | 24.4 | ||||||||||
IV‐16 | IVA | M | 25.5 | R | 0.5 (6/12) | −0.5 | −1.5 | 170 | −1.25 | N | + | Normal | Normal | 20.2 | Normal | L borderline delay |
L | 0.1 (6/60) | −2.25 | −1.0 | 30 | −2.75 | 18.3 | ||||||||||
IV‐17 | IVA | M | 29.4 | R | 0.5 (6/12) | ‐ | ‐ | ‐ | ‐ | N | + | Normal | Normal | 22 | Normal | ‐ |
L | 0.5 (6/12) | 21 |
Notes. MPS, mucopolysaccharidosis; IOP, intraocular pressure; VEP, visual evoked potential; F, female; M, male; R, right; L, left; ‐, not assessed; Y, yes; N, no; +, mild corneal clouding; ++, moderate corneal clouding.